References
- Mir LM, Banoun H, Paoletti C. Introduction of defin-ite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cyto-sol. Exp Cell Res 1988; 175: 15–25.
- Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727–33.
- Hofmann GA, Dev SB, Dimmer S, Nanda GS. Elec-troporation therapy: a new approach for the treatment of head and neck cancer. IEEE Trans Biomed Eng 1999; 46: 752–9.
- Belehradek Jr J, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1994; 1190: 155–63.
- Poddevin B, Orlowski S, Belehradek Jr J, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991; 42 Suppl: S67–75.
- Belehradek Jr J, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mam-mary tumours in mice. Eur J Cancer 1991; 27: 73–6.
- Sersa G, Cemazar M, Miklavcic D. Antitumor effec-tiveness of electrochemotherapy with cis-di-amminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450–5.
- Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin-mediated elec-trochemotherapy of metastatic melanoma. Arch Der-matol 1996; 132: 1353–7.
- Mir LM, Glass LF, Sersa G, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336–42.
- Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experi-ence in malignant melanoma patients. Clin Cancer Res 2000; 6: 863–7.
- Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek Jr J, et al. Electrochemother-apy, a new antitumor treatment: first clinical trial. C R Acad Sci III 1991; 313: 613–8in French.
- Panje WR, Hier MP, Garman GR, Harrell E, Gold-man A, Bloch I. Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 1998; 107 (9 Pt 1): 779–85.
- Tounekti O, Pron G, Belehradek Jr J, Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993; 53: 5462–9.
- Mir LM, Orlowski S, Belehradek Jr J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68–72.
- Nanda GS, Sun FX, Hofmann GA, Hoffman RM, Dev SB. Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. Anticancer Res 1998; 18 (2A): 999–1004.
- Jaroszeski MJ, Coppola D, Pottinger C, Benson K, Gilbert RA, Heller R. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 2001; 37: 422–30.
- Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: po-tentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998; 34: 1213–8.
- Allegretti JP, Panje WR. Electroporation therapy for head and neck cancer including carotid artery involve-ment. Laryngoscope 2001; 111: 52–6.
- Glass LF, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996; 34: 82–6.
- Jaroszeski MJ, Coppola D, Nesmith G, et al. Effects of electrochemotherapy with bleomycin on normal liver tissue in a rat model. Eur J Cancer 2001; 37: 414–21.
- Ogura T. In vivo electroporation: a new frontier for gene delivery and embryology. Differentiation 2002; 70: 163 —71.